Home / Brands / Teva Pharmaceuticals USA
Teva Pharmaceuticals USA Recalls
279 recalls on record · June 27, 2012 to May 13, 2026 · Drugs
Recalls by year
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
April 17, 2013DrugsFDA
Teva Pharmaceuticals USA, Inc. recalls Portia (levonorgestrel and ethinyl estradiol) Tablets, USP, 0.15 mg/0.03 mg, 28-count tablets (containing 21 pink tablet
Hazard: Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.
April 10, 2013DrugsFDA
Teva Pharmaceuticals USA, Inc. recalls CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACE
Hazard: Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
March 20, 2013DrugsFDA
Teva Pharmaceuticals USA, Inc. recalls Terazosin Hydrochloride Capsules, 2 mg, packaged in a) 100-count bottles (NDC 0093-4337-01); and b) 1000-count bottles (
Hazard: Presence of Foreign Tablets/Capsules: Recall is being conducted due to a foreign capsule found in one bottle.
January 23, 2013DrugsFDA
Teva Pharmaceuticals USA, Inc. recalls CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 1896
Hazard: Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life
August 15, 2012DrugsFDA
Teva Pharmaceuticals USA, Inc. recalls Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30
Hazard: Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.
July 11, 2012DrugsFDA
Teva Pharmaceuticals USA, Inc. recalls Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD.
Hazard: Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)
July 4, 2012DrugsFDA
Teva Pharmaceuticals USA, Inc. recalls Zeosa (norethindrone and ethinyl estradiol tablets USP, (chewable), 0.4 mg/0.035 mg, and ferrous fumarate tablets USP, (
Hazard: Impurities/Degradation: This recall is being carried out due to the potential for some lots not meeting impurity specifications.
July 4, 2012DrugsFDA
Teva Pharmaceuticals USA, Inc. recalls Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals US
Hazard: Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.
June 27, 2012DrugsFDA
Teva Pharmaceuticals USA, Inc. recalls Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser contains 91 tablets, 91 Day Regi
Hazard: Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.